花旗集团

最新新闻

• 公司公告
  CI#HSI RC2808I.C: Notice of Valuation of Residual Value of Callable Bull/Bear Contracts issued by CITIC Securities Brokerage (HK) Limited
  HKEX · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains First Majestic Silver(AG.US) With Buy Rating, Cuts Target Price to $25.5
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  MS#CLIFERC2711C.C: Morgan Stanley Asia Products Limited - Notice of Valuation of Residual Value of Callable Bull/Bear Contracts
  HKEX · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $80
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• Press Release: C.H. Robinson Third Quarter 2026 Earnings Release and Conference Call Scheduled for Wednesday, October 28, 2026
  Dow Jones · 2026/10/9
• 公司公告
  Mueller Water Products | 4: Statement of changes in beneficial ownership of securities-Director Healy Brian C.
  SEC · 2026/10/10
• 评级变动
  H.C. Wainwright Maintains Assembly Biosciences(ASMB.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• Should You Be Adding C.H. Robinson Worldwide (NASDAQ:CHRW) To Your Watchlist Today?
  Simply Wall St · 2026/10/10
• 公司公告
  CT#HSI RC2808Z.C: Notice of Valuation of Residual Value of Callable Bull/Bear Contracts issued by Citigroup Global Markets Europe AG
  HKEX · 2026/10/9
• 公司公告
  C.H. Robinson Worldwide | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  SEC · 2026/10/9
• 评级变动
  H.C. Wainwright Sticks to Their Buy Rating for Aligos Therapeutics (ALGS)
  TipRanks · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $100
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• COCA-COLA FEMSA S.A.B. DE C.V. UNITS (REP 3 SER 'B' SHS & 5 SER'L') To Go Ex-Dividend On October 12th, 2026 With 0.10495 USD Dividend Per Share
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $620
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• H.C. Wainwright Downgrades Pacira BioSciences(PCRX.US) to Hold Rating, Cuts Target Price to $36.5
  \u5e02\u573a\u8d44\u8baf · 2026/10/10
• 评级变动
  H.C. Wainwright Maintains Titan Mining(TII.US) With Buy Rating, Maintains Target Price $6.5
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Quantum-Si(QSI.US) With Buy Rating, Maintains Target Price $4
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• UBS Group executive Paul McEwen returns to Citi (C.US) as Chief Technology Officer.
  Zhitong Finance · 2026/10/9
• 公司公告
  Group 1 Automotive | 4: Statement of changes in beneficial ownership of securities-10% Owner Conifer Management, L.L.C.
  SEC · 2026/10/1
• 评级变动
  BofA Securities Maintains C.H. Robinson Worldwide(CHRW.US) With Buy Rating, Maintains Target Price $226
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 公司公告
  T. Rowe Price | 4: Statement of changes in beneficial ownership of securities-Director Golston Allan C.
  SEC · 2026/10/1
• 公司公告
  UTDPLT: Change in Audit Committee - MISS BELVINDER KAUR D/O C. NASIB SINGH
  Bursa Malaysia · 2026/10/1
• 公司公告
  Bumble | 4: Statement of changes in beneficial ownership of securities-10% Owner BTOA - NQ L.L.C.
  SEC · 2026/10/1

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。